THE UGT1A1 GENOTYPE INFLUENCES THE SURVIVAL OF PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA OF INTERMEDIATE CITOGENETIC RISK
Por:
Santa, JD, Romanos, RR, Gelis, GO, Jorda, RC, Pratcorona, M, Puig, CM, Escoda, L, Heras, I, Arnan, M, Vives, S, Salamero, O, Guelquee, NL, Bargay, J, Sampol, A, Garcia, DC, Garcia, A, Quinones, T, Sierra, J, Esteve, J, Tormo, M, Andujar, ET and Giralt, DG
Publicada:
21 oct 2019
Categoría:
Hematology
Resumen:
Filiaciones:
Santa, JD:
Inst Catala Oncol, Girona, Spain
Romanos, RR:
Ist Invest Biomed Girona, Girona, Spain
Gelis, GO:
Registro Hosp Tumors ICO, ICS Girona, Girona, Spain
Jorda, RC:
Inst Catala Oncol, Girona, Spain
Pratcorona, M:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Puig, CM:
Inst Catala Oncol, Girona, Spain
Escoda, L:
Inst Catala Oncol, Tarragona, Spain
Heras, I:
Meseguer Gen Univ Hosp Morales, Murcia, Spain
Arnan, M:
Hosp Vall DHebron Barcelona, Barcelona, Spain
:
Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain
Salamero, O:
Hosp Vall DHebron Barcelona, Barcelona, Spain
Guelquee, NL:
Inst Catala Oncol, Girona, Spain
Bargay, J:
Hosp Son Llatzer, Mallorca, Spain
Sampol, A:
Hosp Univ Son Espases, Palma De Mallorca, Spain
Garcia, DC:
Inst Catala Oncol, Girona, Spain
Garcia, A:
Hosp Arnau Vilanova, Lleida, Spain
Quinones, T:
Inst Catala Oncol, Girona, Spain
Sierra, J:
Hosp Santa Creu & Sant Pau, Barcelona, Spain
Esteve, J:
Hosp Clin Barcelona, Barcelona, Spain
Tormo, M:
Hosp Clin Univ Valencia, Valencia, Spain
Andujar, ET:
Inst Catala Oncol, Girona, Spain
Giralt, DG:
Inst Catala Oncol, Girona, Spain
|